In order to determine MDR efflux pump modulatory properties for the new compounds, a dye-substrate accumulation assay was performed in two T-lymphoma cell lines, i.e., parental (PAR) and multidrug resistant one (MDR) with overexpression of ABCB1. This evidence concerns the gene ABCB1 and lymphoma.